Principal Financial Group
VIVO

Principal Financial Group’s Meridian Bioscience Inc VIVO Stock Holding History

Principal Financial Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-277,881
Closed -$9.23M – 2530
2022
Q4 		$9.23M Sell
277,881
-7,310
-3% -$235K 0.01% 1287
2022
Q3 		$8.99M Sell
285,191
-25,387
-8% -$822K 0.01% 1244
2022
Q2 		$9.45M Sell
310,578
-39
-0% -$1.05K 0.01% 1290
2022
Q1 		$8.06M Sell
310,617
-12,641
-4% -$301K 0.01% 1489
2021
Q4 		$6.59M Sell
323,258
-32,134
-9% -$616K ﹤0.01% 1572
2021
Q3 		$6.84M Sell
355,392
-4,733
-1% -$94.3K ﹤0.01% 1571
2021
Q2 		$7.99M Buy
360,125
+1,541
+0.4% +$32.7K 0.01% 1532
2021
Q1 		$9.41M Buy
358,584
+12,870
+4% +$306K 0.01% 1421
2020
Q4 		$6.46M Sell
345,714
-11,096
-3% -$207K ﹤0.01% 1470
2020
Q3 		$6.06M Buy
356,810
+10,104
+3% +$196K 0.01% 1364
2020
Q2 		$8.07M Buy
346,706
+142
+0% +$2.06K 0.01% 1182
2020
Q1 		$2.91M Sell
346,564
-12,887
-4% -$108K ﹤0.01% 1484
2019
Q4 		$3.51M Buy
359,451
+521
+0.1% +$4.89K ﹤0.01% 1620
2019
Q3 		$3.41M Sell
358,930
-3,119
-0.9% -$32.9K ﹤0.01% 1621
2019
Q2 		$4.3M Buy
362,049
+5,757
+2% +$69.4K ﹤0.01% 1576
2019
Q1 		$6.27M Sell
356,292
-2,883
-0.8% -$48K 0.01% 1462
2018
Q4 		$6.24M Sell
359,175
-97
-0% -$1.65K 0.01% 1422
2018
Q3 		$5.35M Buy
359,272
+12,606
+4% +$195K ﹤0.01% 1582
2018
Q2 		$5.51M Buy
346,666
+6,446
+2% +$96.1K 0.01% 1565
2018
Q1 		$4.83M Buy
340,220
+9,861
+3% +$146K ﹤0.01% 1569
2017
Q4 		$4.63M Sell
330,359
-1,398
-0.4% -$20.5K ﹤0.01% 1594
2017
Q3 		$4.74M Sell
331,757
-2,734
-0.8% -$39.1K ﹤0.01% 1574
2017
Q2 		$5.27M Sell
334,491
-1,155
-0.3% -$16.6K 0.01% 1529
2017
Q1 		$4.63M Buy
335,646
+11,966
+4% +$167K 0.01% 1557
2016
Q4 		$5.73M Buy
323,680
+4,020
+1% +$70.6K 0.01% 1468
2016
Q3 		$6.17M Buy
319,660
+11,218
+4% +$220K 0.01% 1380
2016
Q2 		$6.01M Buy
308,442
+8,150
+3% +$160K 0.01% 1342
2016
Q1 		$6.19M Buy
300,292
+12,610
+4% +$248K 0.01% 1280
2015
Q4 		$5.9M Buy
287,682
+24,837
+9% +$476K 0.01% 1277
2015
Q3 		$4.5M Sell
262,845
-2,625
-1% -$48K 0.01% 1396
2015
Q2 		$4.95M Buy
265,470
+7,047
+3% +$131K 0.01% 1412
2015
Q1 		$4.93M Buy
258,423
+6,162
+2% +$114K 0.01% 1384
2014
Q4 		$4.15M Buy
252,261
+2,157
+0.9% +$37K 0.01% 1472
2014
Q3 		$4.42M Sell
250,104
-2,889
-1% -$56.8K 0.01% 1396
2014
Q2 		$5.22M Sell
252,993
-12,072
-5% -$248K 0.01% 1365
2014
Q1 		$5.78M Buy
265,065
+9,469
+4% +$217K 0.01% 1278
2013
Q4 		$6.78M Buy
255,596
+15,205
+6% +$374K 0.01% 1150
2013
Q3 		$5.68M Sell
240,391
-23,209
-9% -$542K 0.01% 1179
2013
Q2 		$5.67M Buy
+263,600
New +$5.68M 0.01% 1110

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Principal Financial Group's VIVO Position: Q1 2023 in Review

Principal Financial Group sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 277,881 shares — an estimated $9.23M sold.

Principal Financial Group first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $9.45M in Q2 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Principal Financial Group reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Principal Financial Group sold 277,881 Meridian Bioscience Inc shares in Q1 2023, an estimated $9.23M.
  • Principal Financial Group first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • Principal Financial Group's Meridian Bioscience Inc position peaked at $9.45M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Principal Financial Group's 13F filing for Q1 2023, filed 9 May 2023.